Amidst growing concerns and debates over the healthcare insurance system, European pharmaceutical companies have weighed in, highlighting the need to improve access to treatment for patients in Korea.The 2023 EU Chamber of Commerce in Korea (ECCK) White Paper, detailing proposals concerning the regu
Daewoong Pharmaceutical said on Thursday that it signed a four-way agreement with the Korea Medical Institute (KMI), Seers, and Medical AI to supply artificial intelligence (AI)-based electrocardiography (ECG) solutions for public health screening programs. The four companies signed the contract for
Recent advancements in digital health technologies and artificial intelligence (AI) are pushing boundaries in the medical field, but not without concerns.The Ministry of Health and Welfare (MOHW) reported a plan to temporarily apply health insurance benefits to medical AI and digital treatment devic
The overall dwindling of Covid-19 cases has caused countries globally to lower their emergency responses to the virus. Korea, although much later than other countries, is no exception, lowering the infectious disease grade of Covid-19 to level 2, the same as the flu in August. However, a resurgence
Prominent Korean AI medical imaging firms, including Lunit, VUNO, Medical IP, and Coreline Soft, unveiled their key products at the 2023 Korea Clinical Radiology (KCR) conference.The conference is held at COEX, Seoul, from Wednesday to Friday.Lunit showcased all of its Ministry of Food and Drug Safe
HLB has formalized its decision to move from the tech-heavy Kosdaq market to the main exchange of the Kospi market, entering into the shifting process.Industry watchers pay attention to see if HLB, known as the "Kosdaq bellwether," can complete its listing on the Kospi market.HLB said in a public fi
Artificial intelligence (AI) has become a part of our daily lives, from smartphones to self-driving cars. Recently, the "ChatGPT" generative AI model has taken it to the next level, creating a new buzzword, "generative AI." The world's big tech companies are already pouring out generative AI models.
Regulators from across the globe emphasized that the realization of the “Smokefree 2030” policy requires the introduction of rational e-cigarette regulation policies through collaboration between the tobacco industry, regulators, and policymakers.The 13th Global Tobacco & Nicotine Forum 2023 (GTNF 2
As the number of people with musculoskeletal disorders increases due to the growing older adult population, interest is mounting in home rehabilitation exercises that allow people to continue their rehabilitation at home.Rehabilitation exercises can prevent recurrence after surgery and help patients
Patient groups and the Ministry of Food and Drug Safety are running parallel over the safety and efficacy of generic drugs for Parkinson's.Industry insiders are watching how the dispute continues amid mounting patient dissatisfaction with generic drugs.The bickering began in December 2021 when globa
Biogen, maker of the spinal muscular atrophy (SMA) drug Spinraza (nusinersen), and Roche, maker of Evrysdi (risdiplam), recently reached a dramatic agreement with the government by even extending drug price negotiations.Now, the patients are also shifting their attention to dosing standardsAccording
Kakao Healthcare and i-SENS said they have signed a contract to cooperate in the supply of continuous glucose monitoring (CGM) devices and data linkage-based blood glucose management services.The two companies have been discussing cooperation since July last year and had signed a memorandum of under
Alteogen, a company specializing in next-generation biobetters, said on Tuesday that it obtained a U.S. patent regarding its proprietary antibody technology.In particular, the patent covers the technology of the antibody which specifically bind to the folate receptor alpha (FOLR1). The patent was gr
In a strategic move to strengthen its global position, SK pharmteco announced its acquisition of the US-based cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), The Center for Breakthrough Medicines (CBM).With this acquisition, SK pharmteco plans to emerge as a l
Multinational medical device companies are gearing up to showcase their latest breakthroughs and innovations at the much-anticipated Korea Clinical Radiology (KCR) 2023 convention.The convention will be held from Wednesday to Friday at COEX, Seoul.Philips Korea plans to present its new ways to manag
Novartis Korea said it held the seventh emotional support program, CHEERYOU, for patients with rare and intractable diseases in collaboration with the Korean Organization for Rare Diseases (KORD) at the Pine Valley Glamping Site in Pocheon, Gyeonggi Province, last Friday.The CHEERYOU campaign, a fla
Osteoporotic fractures continue to rise due to rapid population aging. By 2025, the number of hip and spine fractures due to osteoporosis is expected to increase by 140 percent. Osteoporotic fractures, typically associated with osteoporosis, are a common geriatric condition.Osteoporosis is a conditi
ST Pharm said it has taken its first step towards becoming the global leader in the oligonucleotide contract development and manufacturing organization (CDMO) domain with the groundbreaking ceremony for its second oligonucleotide facility on Monday.The new plant will be located in Ansan, Gyeonggi Pr
As Korean and foreign pharmaceutical and biotechnology companies are stepping up to develop antibody-drug conjugates (ADCs), Daiichi Sankyo presented its outlook on the future direction of ADC development.Daiichi Sankyo co-developed Enhertu (trastuzumab deruxtecan), a new generation ADC anticancer d
About 8,000 doctors prescribed medical narcotics to themselves annually for the past three years, prompting calls for banning doctors from self-prescribing narcotic drugs by law.These and other facts were revealed at a public debate organized by Rep. Choi Youn-suk of the ruling People Power Party (P